Literature DB >> 16965318

Heterozygosity for a Mendelian disorder as a risk factor for complex disease.

E Sidransky1.   

Abstract

While genetic diseases are generally classified as being either 'simple' monogenic or 'complex' polygenic, the distinction between Mendelian and complex disorders is becoming increasingly blurred. Mendelian disorders may demonstrate qualities more typical of multifactorial diseases through shared clinical presentations, the effect of genetic modifiers, moonlighting proteins, synergistic heterozygosity, disease manifestations in heterozygotes and situations where heterozygosity for a 'simple' disorder proves to be a risk factor for seemingly unrelated complex diseases. A recent example of the last instance is the observation that mutations in glucocerebrosidase, the enzyme deficient in Gaucher disease, may be a risk factor for the development of Parkinson disease and other synucleinopathies. Insights gleaned from the study of Mendelian disorders may ultimately lead to a better understanding of factors influencing complex diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965318     DOI: 10.1111/j.1399-0004.2006.00688.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  22 in total

Review 1.  Genetics of Parkinson's disease.

Authors:  Christine Klein; Ana Westenberger
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Stem cells and genetic disease.

Authors:  A Mackay-Sim; P Silburn
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 3.  On the key role played by altered protein conformation in Parkinson's disease.

Authors:  L F Agnati; E Baldelli; N Andreoli; A S Woods; V Vellani; D Marcellino; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-06-05       Impact factor: 3.575

Review 4.  Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy.

Authors:  B Segarane; A Li; R Paudel; S Scholz; J Neumann; A Lees; T Revesz; J Hardy; C J Mathias; N W Wood; J Holton; H Houlden
Journal:  Neurology       Date:  2009-03-31       Impact factor: 9.910

5.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

6.  The risk of Parkinson's disease in type 1 Gaucher disease.

Authors:  Gilberto Bultron; Katherine Kacena; Daniel Pearson; Michael Boxer; Ruhua Yang; Swati Sathe; Gregory Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2010-02-23       Impact factor: 4.982

7.  Once again, rare diseases provide a spotlight.

Authors:  Tamanna Roshan Lal; Daniel K Borger; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2016-03-05       Impact factor: 4.797

Review 8.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

Review 9.  Genetic susceptibility in Parkinson's disease.

Authors:  Jose Miguel Bras; Andrew Singleton
Journal:  Biochim Biophys Acta       Date:  2008-11-20

10.  Basal laminar drusen caused by compound heterozygous variants in the CFH gene.

Authors:  Camiel J F Boon; B Jeroen Klevering; Carel B Hoyng; Marijke N Zonneveld-Vrieling; Sander B Nabuurs; Ellen Blokland; Frans P M Cremers; Anneke I den Hollander
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.